Compare Moderna, Inc. (MRNA) vs Old Dominion Freight Line Inc (ODFL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Old Dominion Freight Line Inc — how do they compare? Moderna, Inc. trades at $224.38 (market cap $78.65B), while Old Dominion Freight Line Inc trades at $181.98 (market cap $37.68B). The key difference: Moderna, Inc. is far larger — about 2.1× Old Dominion Freight Line Inc's market cap, and Old Dominion Freight Line Inc pays a 0.64% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and Old Dominion Freight Line Inc for 76 Days on average.
| MRNA | ODFL | |
|---|---|---|
Market Cap | $78.65B | $37.68B |
Volume | 37,373,437 | 1,550,104 |
Sector | Health | Industrials |
52-Week High | $203.46 | $248.73 |
52-Week Low | $22.36 | $126.29 |
Typical Hold Time | 59 Days | 76 Days |
Enterprise Value | $74.80B | $37.42B |
Dividend Yield | — | 0.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $214.50, up 9.17% with strong technical momentum. The stock shows bullish moving average signals despite negative profitability metrics, with revenue declining from $18.9B in 2022 to $1.92B in 2025. Recent Nasdaq-100 inclusion creates institutional demand, though Citigroup downgraded to Sell citing valuation concerns after a 500% 2026 rally. The company continues beating EPS expectations despite net losses.
Outlook remains bifurcated between technical strength and fundamental challenges. The cancer vaccine pipeline offers growth potential, but persistent losses and high valuations create headwinds. Near-term momentum may continue from index fund inflows, though profitability concerns warrant caution for long-term investors.
ODFL trades at $181.39, up 3.29% today, with a bearish technical signal despite recent earnings beats. The company maintains strong profitability with a 19.44% net income margin and 24.82% ROE, though revenue has trended down from $6.3B in 2022 to $5.5B in 2025. A recent 4.9% general rate increase effective October 5, 2026, aims to support margins amid cost pressures.
Valuation remains elevated with a P/E of 34.95, posing a risk if growth slows. Analyst consensus is mixed with a $230.93 price target implying 27% upside, but competitive and macroeconomic headwinds in the trucking industry require careful monitoring for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →
